James A Miller

Title: James A Miller: Innovator in Biologically Active Insulin-Like Growth Factor I Production

Introduction

James A Miller is a notable inventor based in Agoura, CA (US). He has made significant contributions to the field of biotechnology, particularly in the production of biologically active insulin-like growth factor I (IGF-I). His innovative methods have the potential to impact various applications in medicine and health.

Latest Patents

James A Miller holds 1 patent for his invention titled "Production of biologically active insulin-like growth factor I from high." This novel method involves refolding reduced IGF-I by introducing additional positive charge at the amino terminal end of the IGF-I molecule through a short leader sequence. This additional positive charge facilitates the refolding of recombinant IGF-I simply by stirring solubilized inclusion body protein for a duration of 2-16 hours, or overnight. The invention also includes a novel fusion protein intermediate of IGF-I attached to the positively charged leader sequence.

Career Highlights

James A Miller is associated with Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to focus on advancing biotechnological methods and improving the production processes of essential proteins.

Collaborations

Throughout his career, James has collaborated with esteemed colleagues, including Philip K Hsieh and Larry B Tsai. These collaborations have contributed to the advancement of research and development in the field of biotechnology.

Conclusion

James A Miller's contributions to the production of biologically active insulin-like growth factor I highlight his innovative spirit and dedication to advancing biotechnology. His work continues to pave the way for future developments in the field.